drugset / Trial / NCT01267305

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

NCT01267305

Completed 362 enrolled Shanghai Zhongshan Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether the use of different dose of LMWH compared with fondaparinux for thromboprophylaxis is efficacious and safety after thoracic surgery.

Timeline

Start
2011-01
Primary completion
2013-04
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fondaparinux Other / unclassified 2.5 mg
Subject Nadroparin Calcium Other / unclassified 4100 iu